share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania

福泰制药 | 4：持股变动声明-高管 Tatsis Ourania

SEC announcement ·  02/28 06:10
牛牛AI助手已提取核心信息
Ourania Tatsis, EVP, Chief Reg. & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate dates. On February 23, 2024, Tatsis sold 3,309 shares of common stock at a price of $431.79 per share. Following this transaction, she disposed of an additional 354 shares on February 26, 2024, at a price of $425.70 per share. The total number of shares sold across both transactions was 3,663, resulting in a combined market value of approximately $1,579,490.91. After these sales, Tatsis directly holds 55,804 shares of Vertex Pharmaceuticals.
Ourania Tatsis, EVP, Chief Reg. & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate dates. On February 23, 2024, Tatsis sold 3,309 shares of common stock at a price of $431.79 per share. Following this transaction, she disposed of an additional 354 shares on February 26, 2024, at a price of $425.70 per share. The total number of shares sold across both transactions was 3,663, resulting in a combined market value of approximately $1,579,490.91. After these sales, Tatsis directly holds 55,804 shares of Vertex Pharmaceuticals.
Vertex Pharmicals Inc.（VRTX）执行副总裁、首席注册和质量官欧拉尼亚·塔西斯在两个不同的日期完成了公司股票的出售。2024年2月23日，塔西斯以每股431.79美元的价格出售了3,309股普通股。在这笔交易之后，她于2024年2月26日以每股425.70美元的价格再出售了354股股票。两笔交易中出售的股票总数为3,663股，总市值约为1,579,490.91美元。在这些出售之后，塔西斯直接持有Vertex Pharmicals的55,804股股票。
Vertex Pharmicals Inc.（VRTX）执行副总裁、首席注册和质量官欧拉尼亚·塔西斯在两个不同的日期完成了公司股票的出售。2024年2月23日，塔西斯以每股431.79美元的价格出售了3,309股普通股。在这笔交易之后，她于2024年2月26日以每股425.70美元的价格再出售了354股股票。两笔交易中出售的股票总数为3,663股，总市值约为1,579,490.91美元。在这些出售之后，塔西斯直接持有Vertex Pharmicals的55,804股股票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成，只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。